The Host Cell Protein (HCP) testing market has been steadily growing, driven by advancements in biopharmaceutical manufacturing and the increasing demand for effective quality control measures. According to recent market research, the HCP testing market size was valued at USD 1.26 billion in 2022 and is projected to reach USD 1.99 billion by 2030, with a compound annual growth rate (CAGR) of...

The mRNA Therapeutics Market size was valued at USD 39.40 billion in 2022 and is expected to grow at USD 45.40 billion by 2030 and grow at a CAGR of 1.5% over the forecast period of 2023-2030. Several key factors are propelling this unprecedented market expansion: Breakthroughs in mRNA technology and delivery systems: Advancements in delivery mechanisms and targeting strategies...